Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=collection%3ACTG
PubPharm (2.036)
1
Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years : Randomized Participant- and Investigator-Blinded Trial to Compare the Clinical Efficacy of Recombinant Influenza Vaccine to Standard Dose Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years in the United States
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults : A Phase 2, Multi-Center, Randomized, Observer-Blind Study, to Evaluate Safety and Immunogenicity of Homologous or Heterologous Priming and Booster Vaccinations With H5N8 or H5N6 MF59-adjuvanted, Cell Culture-derived Influenza Vaccine in Healthy Subjects ≥18 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine : A Phase 2, Randomized, Observer-Blinded Study to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle and Quadrivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine With Matrix-M™ Adjuvant in Healthy Participants ≥ 50 to ≤ 80 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine : A Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety and Immunogenicity of a SARS CoV 2 rS Nanoparticle and Trivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine With Matrix-M™ Adjuvant in Participants ≥ 50 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Incentives for Influenza Vaccination : Financial Incentives for Influenza Vaccination
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine : A Phase 1b, Double-Blind, Randomized, Dose-Escalating, Age De-Escalating, Placebo-Controlled Study to Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine Delivered Intranasally In a Healthy Pediatric Population 6 Months Through 17 Years of Age.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older : Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adults Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above : A Phase I, Parallel, Randomized, Active-controlled, Multi-center, Dose-escalation Study With Early Safety Data Reviews to Assess Safety and Immunogenicity of One Monovalent Modified Influenza mRNA Vaccine Encapsulated in LNP, in Adults Aged 18 to 49 Years and 60 Years and Above.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit : Prospective Clinical Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit as Offered Commercially by Labcorp - A Registry Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines : Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees at Baseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[204]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
2.036
Aufsätze
2.036
E-Artikel
2.036
E-Ressourcen
Zeitschriftentitel
2.004
ClinicalTrials.gov
32
WHO International Clinical Trials Registry Plat...
Thema
2.036
610
2.004
Influenza, Human
1.751
Study Type: Interventional
1.557
Recruitment Status: Completed
775
Medical Condition: Influenza
376
Phase: Phase 3
353
Phase: Phase 2
310
Phase: Phase 4
294
Phase: Phase 1
274
Study Type: Observational
120
Recruitment Status: Recruiting
101
Influenza in Birds
100
Recruitment Status: Unknown status
98
Communicable Diseases
90
Virus Diseases
84
Medical Condition: Influenza, Human
80
Infection
79
Respiratory Tract Infections
68
Phase: Phase 1/Phase 2
66
Recruitment Status: Active, not recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
704
2020-
1.242
2010-2019
90
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.036
Englisch
Haven't found what you're looking for?
Wird geladen...